The folder is named USP21, but the UniProt record (USP21-uniprot.txt), GOA file, and
all existing annotations are for USP25 (UniProt Q9UHP3, UBP25_HUMAN, HGNC:12624).
The UniProt entry lists GN Name=USP25; Synonyms=USP21 — historically USP25 was briefly
called "USP21" / "USP on chromosome 21" in early papers (PubMed:10644437), which is the
likely source of the folder name. The protein here is USP25, not the distinct gene
USP21 (Q9UKM4). All review content below pertains to Q9UHP3 = USP25. The gene_symbol
field is set to USP25 to match the actual record (correct HGNC symbol for Q9UHP3).
USP25 is a cysteine (papain-like, peptidase C19 family) deubiquitinating enzyme (DUB),
EC 3.4.19.12, with an N-terminal UBA + tandem UIM (ubiquitin-interacting motif) region,
a catalytic USP domain (active-site Cys-178), and a C-terminal region mediating
oligomerization (active homodimer vs. inhibited homotetramer).
[file:human/USP21/USP21-uniprot.txt "Belongs to the peptidase C19 family"]
[file:human/USP21/USP21-uniprot.txt "ACT_SITE 178"]
Hydrolyzes ubiquitin (and SUMO/ubiquitin-like) from substrates; cleaves both K48- and
K63-linked chains.
[file:human/USP21/USP21-uniprot.txt "Deubiquitinating enzyme that hydrolyzes ubiquitin moieties conjugated to substrates"]
EXP catalytic activity: PMID:23042150 (IL-17/TRAF), PMID:37339955 (KEAP1-NRF2).
C178S abrogates DUB activity. [file:human/USP21/USP21-uniprot.txt "C->S: Abrogates deubiquitinating activity"]
SUMOylated at Lys-99 (SUMO2/3 preferred) which impairs Ub binding/hydrolysis; the N-terminal
SIM mediates paralog-specific SUMO binding (PMID:18538659). -> GO:0032183 SUMO binding.
Ubiquitinated by SMURF1 (K48) -> degradation (PMID:29518389). Phosphorylated by SYK
(PMID:19909739). Oligomerization (tetramer = inhibited; dimer = active) regulates activity
(PMID:30478318, PMID:30926243).
Cytoplasm/cytosol (multiple EXP/IDA: PMID:19440361, PMID:28619731, PMID:38875478, HPA).
ER membrane association in ERAD context (PMID:22590560, IDA). Nucleus is IEA-only (from
UniProtKB-SubCell keyword, transient nuclear punctate in myotubes for USP25m) — weak.
Heterozygous variants cause idiopathic generalized epilepsy 19 (EIG19); a C-terminal
truncation is a gain-of-function (forms active dimers, not inhibited tetramers)
(PMID:38875478).
Despite the batch theme, USP25's documented roles are Wnt/tankyrase, KEAP1-NRF2, IL-17/innate
immunity, and ERAD — not collided-ribosome surveillance. No strong evidence ties USP25 to
ribosome-associated quality control. (The RQC-associated DUB framing in the task note appears
to belong to USP21, a different gene.)